Intracranial administration of adenovirus expressing HSV-TK in combination with ganciclovir produces a dose-dependent, self-limiting inflammatory response

Human Gene Therapy

Volumn 8, Issue 8, 1997, Pages 943-954

  Smith, Jason G ^a   Raper, Steven E ^a   Wheeldon, Eric B ^b   Hackney, David ^a   Judy, Kevin ^a   Wilson, James M ^a   Eck, Stephen L ^a,c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR; THYMIDINE KINASE; VIRUS ENZYME;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CONTROLLED STUDY; GLIOSIS; GRAND MAL SEIZURE; HERPES SIMPLEX VIRUS; INFLAMMATION; MALE; MENINGITIS; NECROSIS; NONHUMAN; RAT; RHESUS MONKEY;

EID: 0031010215     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.8-943     Document Type: Article

References (37)

1. BAJOCCHI, G., FELDMAN, S.H., and CRYSTAL, R.G. (1993). Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genet. 3, 229-234.
2. BETZ, A.L., YANG, G.Y., and DAVIDSON, B.L. (1995). Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J. Cerebral Blood Flow Metab. 15, 547-551.
3. BOVIATSIS, E.J., CHASE, M., WEI, M.X., TAMIYA, T., HURFORD, R.K., JR., KOWALL, N.W., TEPPER, R.I., BREAKEFIELD, X.O. and CHIOCCA, E.A. (1994). Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. Hum. Gene Ther. 5, 183-191.
4. CHENG, M.K., MCKEAN, J., BOISVERT, D., and TULIP, J. (1986). Photoradiation therapy: current status and applications in the treatment of brain tumors. Surg. Neurol. 25, 423-435.
5. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
6. DAVIDSON, B.L., ALLEN, E.D., KOZARSKY, K.F., WILSON, J.M., and ROESSLER, B.L. (1993). A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet. 3, 219-223.
7. DRIESSE, M.J., SMITT, P.A.E.S., VINCENT, A.J.P.E., AVEZAAT, C.J.J., VECHT, C., KROS, M., HOOGERBRUGGE, P.M., BEKKUM, D.W.V., VALERIO, D., and BOUT, A. (1996). A toxicity study of recombinant adenovirus (IG.Ad.MPLI.TK) to normal brain tissue and meninges of rats and rhesus monkeys. Cancer Gene Ther. 3(6), S34.
8. ECK, S.L., and WILSON, J.M. (1996). Gene-based therapy. In The Pharmacological Basis of Therapeutics. J.G. Hardman, L.E. Limbird, P.B. Molinoff, and R.W. Ruddon, eds. (McGraw-Hill, New York), pp. 94-96.
9. ECK, S.L., ALAVI, J.B., ALAVI, A., DAVIS, A., HACKNEY, D., JUDY, K., MOLLMAN, J., PHILLIPS, P.C., WHEELDON, E.B., and WILSON, J.M. (1996). Clinical protocol: treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: A phase I trial. Hum. Gene Ther. 7, 1465-1482.
10. ENGELHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
11. FREEMAN, S.M., ABBOUD C.N., WHARTENBY, K.A., PACKMAN, C.H., KOEPLIN, D.S., MOOLTEN, F.L., and ABRAHAM, G.N. (1993). The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274-5283.
12. GOODMAN, J.C., TRASK, T.W., CHEN, S.-H., WOO, S.L.C., GROSSMAN, R.G., CAREY, K.D., HUBBARD, G.B., CARRIER, D.A., RAJAGOPALAN, S., AGUILAR-CORDOVA, E., and SHINE, H.D. (1996). Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: Pathologic, radiologic, and molecular studies. Hum. Gene Ther. 7, 1241-1250.
13. GUTIN, P.H., LEIBEL, S.A., WARA, W.M., CHOUCAIR, A., LEVIN, V.A., PHILIPS, T.L., SILVER, P., DA SILVA, V., EDWARDS, M.S., DAVIS, R.L., WEAVER, K.A., and LAMB, S. (1987). Recurrent malignant gliomas: Survival following interstitial brachytherapy with high-activity iodine-125 sources. J. Neurosurg. 67, 864-873.
14. JAFFE, H.A., DANEL, C., LONGENECKER, G., METZGER, M., SETOGUCHI, Y., ROSENFELD, M.A., GANT, T.W., THORGEIRSSON, S.S., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., PAVIRANI, A., LECOCQ, J.-P., and CRYSTAL, R.G. (1992). Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet. 1, 372-378.
15. KORNBLITH, P.L., and WALKER, M. (1988). Chemotherapy for malignant gliomas. J. Neurosurg. 68, 1-17.
16. LE GAL LA SALLE, G., ROBERT, J.J., BERRARD, S., RIDOUX, V., SRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., and MALLET, J. (1993). An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259, 988-990.
17. LEIBEL, S.A., SCOTT, C.B., and LOEFFLER, J.S. (1994). Contemporary approaches to the treatment of malignant gliomas with radiation therapy. Semin. Oncol. 21, 198-219.
18. LEMARCHAND, P., JONES, M., YAMADA, I., and CRYSTAL, R.G. (1993). In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circulation Res. 72, 1132-1138.
19. MOOLTEN, F.L. (1986). Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res. 46, 5276-5581.
20. MOOLTEN, F.L., WELLS, J.M., HEYMAN, R.A., and EVANS, R.M. (1990). Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum. Gene Ther. 1, 125-134.
21. ONOYAMA, Y., ABE, M., YABUMOTO, E., SAKAMOTO, T., and NISHIDAI, T. (1976). Radiation therapy in the treatment of glioblastoma. Am. J. Roentgenol. 126, 481-492.
22. PACINI, D.L., DUBOVI, E.J., and WALLACE, A.C., JR. (1984). A new animal model for human respiratory tract disease due to adenovirus. J. Infect. Dis. 150, 92-97.
23. PRINCE, G.A., PORTER, D.D., JENSON, A.B., HORSWOOD, R.L., CHANOCK, R.M., and GINSBERG, H.S. (1993). Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus). J. Virol. 67, 101-111.
24. RAM, Z., CULVER, K.W., WALBRIDGE, S., FRANK, J.A., BLAESE, R.M., and OLDFIELD, E.H. (1993). Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. J. Neurosurg. 79, 400-407.
25. RORKE, L.B., RUBIN, B.A., and MYERS, J. (1973). Neurovirulence of adenoviruses. J. Neuropathol. Exp. Neurol. 32, 161-162.
26. SALAZAR, O.M., RUBIN, P., FELDSTEIN, M.L., and PIZZUTIELLO, R. (1979). High dose radiation therapy in the treatment of malignant gliomas: final report. Int. J. Radiat. Oncol. Biol. Phys. 5, 1733-1740.
27. SALCMAN, M., and SAMARAS, G.M. (1983). Interstitial microwave hyperthermia for brain tumors. Results of a phase-1 clinical trial. J. Neurooncol. 1, 225-236.
28. SHAPIRO, W.R., GREEN, S.B., BURGER, P.C., MAHALEY, M.S., JR., SELKER, R.G., VANGILDER, J.C., ROBERTSON, J.T., RANSOHOFF, J., MEALEY, J., JR., STRIKE, T.A. and PISTENMAA, D.A. (1989). Randomized trial of three chemotherapy regimens and two radiotherapy reigmens and two radiotherapy regimens in post-operative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J. Neurosurg. 71, 1-9.
29. SIMON, R.H., ENGELHARDT, J.F., YANG, Y., ZEPEDA, M., WEBER-PENDLETON, S., GROSSMAN, M., and WILSON, J.M. (1993). Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum. Gene Ther. 4, 771-780.
30. SMYTHE, W.R., HWANG, H.C., AMIN, K.M., ECK, S.L., DAVIDSON, B.L., WILSON, J.M., KAISER, L.R., and ALBELDA, S.M. (1994). Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res. 54, 2055-2059.
31. SMYTHE, W.R., KAISER, L.R., HWUANG, H.C., AMIN, K.M., PILEWSKI, J.M., ECK, S.L., WILSON, J.M., and ALBELDA, S.M. (1994). Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma. Ann. Thorac. Surg. 57, 1395-1401.
32. WALKER, M.D., GREEN, S.B., BYAR, D.P., ALEXANDER, E., JR., BATZDORF, U., BROOKS, W.H., HUNT, W.E., MACCARTY, C.S., MAHALEY, M.S., JR., MEALEY, J., JR., OWENS, G., RANSOHOFF, J.D, ROBERTSON, J.T., SHAPIRO, W.R., SMITH, K.R., JR., WILSON, C.B., and STRIKE, T.A. (1980). Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N. Engl. J. Med. 303, 1323-1329.
33. WINTERS, W., KADO, R., and ADEY, W. (1969). A Stereotaxic Brain Atlas for Macaca Nemestrina. (University of California Press, Berkeley and Los Angeles).
34. WORGALL, S., WOLFF, G., FALCK-PEDERSEN, E., and CRYSTAL, R.G. (1997). Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8, 37-44.
35. YANG, Y., LI, Q., ERTL, H.C., and WILSON, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.
36. YEI, S., MITTEREDER, N., WERT, S., WHITSETT, J.A., WILMOTT, R.W., and TRAPNELL, B.C. (1994). In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis trans-membrane conductance regulator cDNA to the lung. Hum. Gene Ther. 5, 731-744.
37. ZABNER, J., PETERSEN, D.M., PUGA, A.P., GRAHAM, S.M., COUTURE, L.A., KEYES, L.D., LUKASON, M.J., ST GEORGE, J.A., GREGORY, R.J., SMITH, A.E., and WELSH, M.J. (1994). Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nature Genet. 6, 75-83.